Related references
Note: Only part of the references are listed.Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration
James L. Grijalva et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2014)
Hippo Pathway Activity Influences Liver Cell Fate
Dean Yimlamai et al.
CELL (2014)
The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment
Randy Johnson et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
SIRT1 regulates YAP2-mediated cell proliferation and chemoresistance in hepatocellular carcinoma
B. Mao et al.
ONCOGENE (2014)
MEK1 promotes YAP and their interaction is critical for tumorigenesis in liver cancer
Lanlan Li et al.
FEBS LETTERS (2013)
Mutual Interaction Between YAP and CREB Promotes Tumorigenesis in Liver Cancer
Jiayi Wang et al.
HEPATOLOGY (2013)
In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration
Meritxell Huch et al.
NATURE (2013)
Interhemispheric Functional Connectivity and Its Relationships with Clinical Characteristics in Major Depressive Disorder: A Resting State fMRI Study
Li Wang et al.
PLOS ONE (2013)
The p130 Isoform of Angiomotin Is Required for Yap-Mediated Hepatic Epithelial Cell Proliferation and Tumorigenesis
Chunling Yi et al.
SCIENCE SIGNALING (2013)
Angiomotin'g YAP into the Nucleus for Cell Proliferation and Cancer Development
Wanjin Hong
SCIENCE SIGNALING (2013)
Bile Acids Activate YAP to Promote Liver Carcinogenesis
Sayeepriyadarshini Anakk et al.
CELL REPORTS (2013)
The Ets Transcription Factor GABP Is a Component of the Hippo Pathway Essential for Growth and Antioxidant Defense
Hongtan Wu et al.
CELL REPORTS (2013)
The Hippo pathway and human cancer
Kieran F. Harvey et al.
NATURE REVIEWS CANCER (2013)
Liver Progenitor Cells Yield Functional Hepatocytes in Response to Chronic Liver Injury in Mice
Regina Espanol-Suner et al.
GASTROENTEROLOGY (2012)
Hepatitis B Virus X Protein Modulates Oncogene Yes-Associated Protein by CREB to Promote Growth of Hepatoma Cells
Tao Zhang et al.
HEPATOLOGY (2012)
A Novel Acetylation Cycle of Transcription Co-activator Yes-associated Protein That Is Downstream of Hippo Pathway Is Triggered in Response to SN2 Alkylating Agents
Shoji Hata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Wnt/β-Catenin Signaling Regulates Yes-associated Protein (YAP) Gene Expression in Colorectal Carcinoma Cells
Wesley M. Konsavage et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice
Miki Nishio et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
The YAP and TAZ transcription co-activators: Key downstream effectors of the mammalian Hippo pathway
Wanjin Hong et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)
Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein
Bin Zhao et al.
GENES & DEVELOPMENT (2011)
Human Hepatic Stem Cell and Maturational Liver Lineage Biology
Rachael Turner et al.
HEPATOLOGY (2011)
Angiomotin-like Proteins Associate with and Negatively Regulate YAP1
Wenqi Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin
Siew Wee Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Combined deletion of Fxr and Shp in mice induces Cyp17a1 and results in juvenile onset cholestasis
Sayeepriyadarshini Anakk et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor
Murugan Paramasivam et al.
MOLECULAR BIOLOGY OF THE CELL (2011)
Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance
Dawang Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties
Angela M. Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Jagged1 in the portal vein mesenchyme regulates intrahepatic bile duct development: insights into Alagille syndrome
Jennifer J. Hofmann et al.
DEVELOPMENT (2010)
The Merlin/NF2 Tumor Suppressor Functions through the YAP Oncoprotein to Regulate Tissue Homeostasis in Mammals
Nailing Zhang et al.
DEVELOPMENTAL CELL (2010)
Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver
Samira Benhamouche et al.
GENES & DEVELOPMENT (2010)
A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF beta-TRCP
Bin Zhao et al.
GENES & DEVELOPMENT (2010)
Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression
Hai Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver
Li Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis
Kwang-Pyo Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Yes-Associated Protein Is an Independent Prognostic Marker in Hepatocellular Carcinoma
Michelle Z. Xu et al.
CANCER (2009)
Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 Oncogene
Dawang Zhou et al.
CANCER CELL (2009)
Notch signaling controls liver development by regulating biliary differentiation
Yiwei Zong et al.
DEVELOPMENT (2009)
MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation
Maria Praskova et al.
CURRENT BIOLOGY (2008)
Yes-Associated Protein (YAP) is a critical mediator of c-Jun-dependent apoptosis
S. A. Danovi et al.
CELL DEATH AND DIFFERENTIATION (2008)
YAP1 increases organ size and expands undifferentiated progenitor cells
Fernando D. Camargo et al.
CURRENT BIOLOGY (2007)
Elucidation of a universal size-control mechanism in Drosophila and mammals
Jixin Dong et al.
CELL (2007)
Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice
Insook Kim et al.
CARCINOGENESIS (2007)
Mob as tumor suppressor is activated by Hippo kinase for growth inhibition in Drosophila
Xiaomu Wei et al.
EMBO JOURNAL (2007)
Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor
Fan Yang et al.
CANCER RESEARCH (2007)
Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon
Michael Overholtzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Lars Zender et al.
CELL (2006)
Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration
WD Huang et al.
SCIENCE (2006)
Expression of Notch-1 and its ligand Jagged-1 in rat liver during liver regeneration
C Köhler et al.
HEPATOLOGY (2004)
Share Paper
